Učitavanje...

Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells

Glucagon like peptide 1 (GLP-1) based therapies are now widely used for the treatment of type 2 diabetes. Developing our understanding of intestinal GLP-1 release may facilitate the development of new therapeutics aimed at targeting the GLP-1 producing L-cells. This study was undertaken to character...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rogers, G J, Tolhurst, G, Ramzan, A, Habib, A M, Parker, H E, Gribble, F M, Reimann, F
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3060588/
https://ncbi.nlm.nih.gov/pubmed/21224236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/jphysiol.2010.198069
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!